[ALNY] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
27-Oct-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -46.33%
YoY- -98.48%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 318,754 319,290 335,035 264,306 224,818 213,259 258,535 15.02%
PBT -274,209 -172,362 -207,021 -405,943 -274,673 -239,356 -260,302 3.54%
Tax 1,815 1,739 472 -23 2,729 985 -1,842 -
NP -276,024 -174,101 -207,493 -405,920 -277,402 -240,341 -258,460 4.49%
Tax Rate - - - - - - - -
Total Cost 594,778 493,391 542,528 670,226 502,220 453,600 516,995 9.82%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -86.59 -54.53 -61.93 -153.58 -123.39 -112.70 -99.97 -9.15%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -2.21 -1.40 -1.68 -3.32 -2.29 -2.00 -2.16 1.54%
EPS Diluted -2.21 -1.40 -1.68 -3.32 -2.29 -2.00 -2.16 1.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.